Risk factors
Omeros (OMER) risk factors
Item 1A of every Omeros Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors35 risks11 new3 dropped11 reworded
Omeros achieved FDA approval for YARTEMLEA in December 2025, shifting its primary business focus to commercial execution.
Filed Mar 31, 2026 - FY2024 10-K risk factors27 risks
Substantial doubt exists regarding the company's ability to continue as a going concern, driven by cumulative losses and high cash burn.
Filed Mar 31, 2025